OBJECTIVE: To examine the relationship of depression severity to circulating endothelin-1 (ET-1), which has previously been linked to plaque rupture and postacute coronary syndrome (ACS) survival. Depression carries an independent two- to four-fold increased risk of early morbidity and mortality after ACS. The pathway(s) linking depression to event-free survival remains to be determined. METHODS: Patients with documented history of coronary artery disease (n = 101) provided a resting morning blood sample that was assayed for ET-1, and they completed the Beck Depression Inventory (BDI). ET-1 was treated as a log-transformed continuous variable (logET-1), and as a dichotomous variable using a post-ACS risk threshold previously reported (≥1.16 fmol/mL). RESULTS: BDI score was related to logET-1 in both unadjusted and adjusted models. In addition, unadjusted and adjusted logistic regression models with dichotomous ET-1 revealed that, for each point increase in BDI score, there was approximately a 14% increased likelihood of being at or above ET-1 risk threshold. Secondary logistic regression models demonstrated a >3.5-fold likelihood of being at or above this risk threshold in association with a BDI score of ≥10. CONCLUSIONS: Depression symptom severity predicts ET-1 elevation that has previously been linked to post-ACS survival, with the greatest risk of elevation among those patients with worse depression symptoms. This link may identify a vulnerability to triggered ACS and poorer survival associated with depression. Future research should establish whether the observed relationship of depressive symptoms to ET-1 level mediates the link between depression and survival.
OBJECTIVE: To examine the relationship of depression severity to circulating endothelin-1 (ET-1), which has previously been linked to plaque rupture and postacute coronary syndrome (ACS) survival. Depression carries an independent two- to four-fold increased risk of early morbidity and mortality after ACS. The pathway(s) linking depression to event-free survival remains to be determined. METHODS:Patients with documented history of coronary artery disease (n = 101) provided a resting morning blood sample that was assayed for ET-1, and they completed the Beck Depression Inventory (BDI). ET-1 was treated as a log-transformed continuous variable (logET-1), and as a dichotomous variable using a post-ACS risk threshold previously reported (≥1.16 fmol/mL). RESULTS: BDI score was related to logET-1 in both unadjusted and adjusted models. In addition, unadjusted and adjusted logistic regression models with dichotomous ET-1 revealed that, for each point increase in BDI score, there was approximately a 14% increased likelihood of being at or above ET-1 risk threshold. Secondary logistic regression models demonstrated a >3.5-fold likelihood of being at or above this risk threshold in association with a BDI score of ≥10. CONCLUSIONS:Depression symptom severity predicts ET-1 elevation that has previously been linked to post-ACS survival, with the greatest risk of elevation among those patients with worse depression symptoms. This link may identify a vulnerability to triggered ACS and poorer survival associated with depression. Future research should establish whether the observed relationship of depressive symptoms to ET-1 level mediates the link between depression and survival.
Authors: L V Borovikova; S Ivanova; M Zhang; H Yang; G I Botchkina; L R Watkins; H Wang; N Abumrad; J W Eaton; K J Tracey Journal: Nature Date: 2000-05-25 Impact factor: 49.962
Authors: Antonio B Fernandez; Robert Soufer; Dorothea Collins; Aaron Soufer; Hooman Ranjbaran; Matthew M Burg Journal: Psychosom Med Date: 2010-04-05 Impact factor: 4.312
Authors: L Ghiadoni; A E Donald; M Cropley; M J Mullen; G Oakley; M Taylor; G O'Connor; J Betteridge; N Klein; A Steptoe; J E Deanfield Journal: Circulation Date: 2000-11-14 Impact factor: 29.690
Authors: Andrew W Goddard; Susan G Ball; James Martinez; Michael J Robinson; Charles R Yang; James M Russell; Anantha Shekhar Journal: Depress Anxiety Date: 2010-04 Impact factor: 6.505
Authors: Judith H Lichtman; J Thomas Bigger; James A Blumenthal; Nancy Frasure-Smith; Peter G Kaufmann; François Lespérance; Daniel B Mark; David S Sheps; C Barr Taylor; Erika Sivarajan Froelicher Journal: Circulation Date: 2008-09-29 Impact factor: 29.690
Authors: Luba Yammine; Lorraine Frazier; Nikhil S Padhye; Jennifer E Sanner; Matthew M Burg Journal: J Psychosom Res Date: 2017-05-23 Impact factor: 3.006
Authors: Luba Yammine; Lorraine Frazier; Nikhil S Padhye; Matthew M Burg; Janet C Meininger Journal: J Psychosom Res Date: 2014-08-02 Impact factor: 3.006
Authors: Christopher M Celano; Eleanor E Beale; Scott R Beach; Arianna M Belcher; Laura Suarez; Shweta R Motiwala; Parul U Gandhi; Hanna Gaggin; James L Januzzi; Brian C Healy; Jeff C Huffman Journal: Psychosom Med Date: 2017-04 Impact factor: 4.312
Authors: Matthew M Burg; Donald Edmondson; Daichi Shimbo; Jonathan Shaffer; Ian M Kronish; William Whang; Carmela Alcántara; Joseph E Schwartz; Paul Muntner; Karina W Davidson Journal: Prog Cardiovasc Dis Date: 2013-04-06 Impact factor: 8.194
Authors: Elizabeth N Madva; Christopher M Celano; Diana M Smith; James L Januzzi; Jeff C Huffman Journal: J Psychosom Res Date: 2020-11-11 Impact factor: 3.006